Hasil Pencarian - Viktor Rotbain Curovic

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

    Effect of liraglutide on expression of inflammatory genes in type 2 diabetes oleh Emilie H. Zobel, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Andreas Kjaer, Tine W. Hansen, Peter Rossing, Joachim Størling

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Effect of Liraglutide on Vascular Inflammation Evaluated by [<sup>64</sup>Cu]DOTATATE

    Effect of Liraglutide on Vascular Inflammation Evaluated by [<sup>64</sup>Cu]DOTATATE oleh Emilie H. Zobel, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Lars Jorge Diaz, Tine W. Hansen, Peter Rossing, Andreas Kjaer

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor oleh Viktor Rotbain Curovic, Morten B. Houlind, Tine W. Hansen, Jesper Eugen-Olsen, Jens Christian Laursen, Mie K. Eickhoff, Frederik Persson, Peter Rossing, Peter Rossing

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial oleh Andreas Kjær, Peter Rossing, Emilie H Zobel, Asger Wretlind, Rasmus S Ripa, Viktor Rotbain Curovic, Bernt J von Scholten, Tommi Suvitaival, Tine W Hansen, Cristina Legido-Quigley

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial

    Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial oleh Jacob K. Jensen, Emilie H. Zobel, Emilie H. Zobel, Bernt J. von Scholten, Bernt J. von Scholten, Viktor Rotbain Curovic, Tine W. Hansen, Peter Rossing, Andreas Kjaer, Rasmus S. Ripa

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes oleh Luis F. Ferreira-Divino, Tommi Suvitaival, Viktor Rotbain Curovic, Nete Tofte, Kajetan Trošt, Ismo M. Mattila, Simone Theilade, Signe A. Winther, Tine W. Hansen, Marie Frimodt-Møller, Cristina Legido-Quigley, Peter Rossing

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

    Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials oleh Asger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, Tommi Suvitaival, Jin Xu, Emilie Hein Zobel, Bernt Johan von Scholten, Rasmus Sejersten Ripa, Andreas Kjaer, Tine Willum Hansen, Tina Vilsbøll, Henrik Vestergaard, Peter Rossing, Cristina Legido-Quigley

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes

    Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes oleh Peter Rossing, Simone Theilade, Christian Stevns Hansen, Marie Frimodt-Moller, Viktor Rotbain Curovic, Tine W Hansen, Cristina Legido-Quigley, Nete Tofte, Tarunveer S Ahluwalia, Ismo Matias Mattila, Brede A Sørland, Siddhi Y Jain, Karolina Sulek, Kajetan Trost, Signe Abitz Winther

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial oleh Asger Wretlind, Asger Wretlind, Emilie Hein Zobel, Andressa de Zawadzki, Rasmus Sejersten Ripa, Rasmus Sejersten Ripa, Viktor Rotbain Curovic, Bernt Johan von Scholten, Bernt Johan von Scholten, Ismo Matias Mattila, Tine Willum Hansen, Andreas Kjær, Henrik Vestergaard, Henrik Vestergaard, Peter Rossing, Peter Rossing, Cristina Legido-Quigley, Cristina Legido-Quigley

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: